News

Singapore, October 2019 – X-ZELL has been ranked amongst the 50 leading health tech start-ups in Asia for the second year running. Every year, the prestigious list is compiled by Singapore-based analytics and advisory firm, Galen Growth Asia, which has developed a...

Bangkok/Basel, August 2019 (via PR Newswire) – An international research team at Mahidol University in Bangkok, Thailand, has demonstrated the potential for a new blood test to detect clinically significant prostate cancer in high-risk patients, as...

Singapore, July 2019 – Singapore-based rare cell detection specialist, X-ZELL, is about to embark on the most ambitious research and innovation project in the company’s history. Nicknamed Cloud Atlas, the landmark project will consolidate the image material collected...

Singapore, May 2019 – X-ZELL, only recently named one of Asia’s 20 most innovative health tech start-ups, today opened its new global headquarters at Paya Lebar Square in Singapore, conveniently located between Changi Airport and the city's vibrant Central Business...

Singapore, April 2019 – Rare cell detection specialist, X-ZELL, has been shortlisted as a Finalist for the 2019 HealthInvestor Asia Awards. According to HealthInvestor Asia, X-ZELL has been nominated in the “Diagnostics Deal of the Year” category following the signing...

Singapore, February 2019 – Rare cell detection specialist X-ZELL is proud to announce the world premiere of the world’s first 9-colour immunostaining system. Originally designed to enable the company’s headline-making research into next-generation biomarkers, the...

Singapore, February 2019 – Singaporean medical technology start-up X-ZELL will preview the production version of the world's first slide-based, eight-channel immunostaining solution at the 2019 Medlab Asia Pacific trade show, to be held at Singapore’s Suntec...

X-ZELL is now officially partnering with Singapore’s DxD Hub.   Singapore, December 2018 – In a move that will accelerate the company's capabilities and scale up its commercialisation and product development processes, X-ZELL has partnered with Singapore’s...

Amsterdam, November 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has used the 2018 European Multidisciplinary Congress on Urological Cancers (EMUC18) in Amsterdam as a platform to present new insights into the origin and clinical utility of Circulating Endothelial Cells...

Singapore, November 2018 – X-ZELL  has been one of eight promising biotechnology start-ups selected to exhibit at the inaugural A*CCELERATE NOW exhibition in Singapore. The landmark event – held in a move to celebrate the re-branding of ETPL, the commercialisation arm...